← All diseases Cancer

Kidney cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (65)Meta-analysis (28)Treatment guideline (1)Systematic review (22)Randomized trial (7)Phase 3 study (7)Clinical trial (601)Review article (196)Early study (phase 1 or 2) (40)Case reports (295)Laboratory or animal study (25)Commentary or editorial (40)Retracted publication (5) Studies currently recruiting participants only (46)

Filter

Publications and studies (2200)

• Exploring the material basis and mechanism of action of clinacanthus nutans in treating renal cell carcinoma based on metabolomics and network pharmacology. (2023/10/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical translational research of liquid biopsy applications in prostate cancer and other urological cancers. (2023/10/19) ♡
• Unexpected and Rare Sites of Metastasis in Oncologic Patients. (2023/10/10) ♡
• Diagnostic value of repeated comprehensive investigation with CT urography and cystoscopy for recurrent macroscopic haematuria. (2023/10/06) ♡
• Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway. (2023/10/05) ♡
• Dietary Fish and n-3 Polyunsaturated Fatty Acid Consumption, and Renal Cell Carcinoma Risk in Japan: The Japan Public Health Center-Based Prospective Study. (2023/10/02) ♡
• Current perspective on the impact of endogenous retroviruses in clear cell renal cell carcinoma. (2023/10/01) ♡
• A 90-day feeding study of genetically modified maize LP007-1 in wistar han RCC rats. (2023/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Succinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer. (2023/10/01) ♡
• 2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience. (2023/10/01) ♡
• Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses. (2023/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis. (2023/10/01) ♡
• Post Renal Transplant Malignancies; A Basic Concept. (2023/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Comprehensive treatment of von Hippel-Lindau disease: A case report. (2023/09/20) ♡
• Synthesis of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor, 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977, Belzutifan); Efficient Replication of Established Approaches. (2023/09/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. (2023/09/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cutaneous Acral Metastasis from Renal Cell Carcinoma-a Case Report. (2023/09/01) ♡
• Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology. (2023/09/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical Efficacy of Bushen Yiqi Fuzheng Decoction Combined with Sunitinib in the Treatment of Postoperative Patients with Renal Cell Carcinoma and Its Influence on Their Immune Function. (2023/09/01) ♡
• Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients. (2023/09/01) ♡
• A novel case of EUS-guided targeted radiofrequency ablation of metastatic duodenal renal cell carcinoma. (2023/09/01) ♡
• The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase. (2023/08/14) ♡
• Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma. (2023/08/11) ♡
• PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. (2023/08/02) ♡
• The Action Mechanisms, Anti-Cancer and Antibiotic-Modulation Potential of Vaccinium myrtillus L. Extract. (2023/08/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. (2023/08/01) ♡
• [Expression of SCD1 in TFE3-rRCC and its effect on proliferation and migration]. (2023/08/01) ♡
• Chinese herbal compound SanHuang decoction reverses axitinib resistance in ccRCC through regulating immune cell infiltration by affecting ADAMTS18 expression. (2023/07/15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs. (2023/07/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: durable complete response to pembrolizumab plus lenvatinib in a metastatic upper tract urothelial carcinoma patient with high tumor mutational burden and an immune-active tumor microenvironment. (2023/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies. (2023/07/01) ♡
• The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. (2023/07/01) ♡
• Impact of overweight and obesity on US renal cell carcinoma incidence trends (1995-2018). (2023/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct. (2023/07/01) ♡
• Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. (2023/07/01) ♡
• AF9 targets acetyl-modified STAT6 to diminish purine metabolism and accelerate cell apoptosis during metastasis. (2023/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Renal Allograft Malakoplakia Presenting as a Pseudotumoral Lesion. (2023/07/01) ♡
• HISTOPATHOLOGIC FEATURES OF KIDNEY TUMORS AND COMPARISON OF PATIENTS TREATED WITH RADICAL AND PARTIAL NEPHRECTOMY AT OSIJEK UNIVERSITY HOSPITAL CENTER FROM 2017 UNTIL THE END OF 2021. (2023/07/01) ♡
• TRENDS IN SURGICAL MANAGEMENT OF RENAL NEOPLASMS: SINGLE CENTER RESULTS IN THE LAST DECADE. (2023/07/01) ♡
• LAPAROSCOPIC ADRENAL-SPARING SURGERY CASE SERIES: PARTIAL ADRENALECTOMY AND CYST RESECTION. (2023/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up. (2023/06/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sorafenib-Based Drug Delivery Systems: Applications and Perspectives. (2023/06/09) ♡
• A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries. (2023/06/01) ♡
• The LMR-SSIGN-MAPS model predicts disease-free survival in patients with localized clear cell renal cell carcinoma. (2023/06/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of reduced-calcium and high-calcium cheddar cheese consumption on the excretion of faecal fat: a 2-week cross-over dietary intervention study. (2023/06/01) ♡
• Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients. (2023/06/01) ♡
• The association of circulating endocannabinoids with cancer cachexia: A cross-sectional study. (2023/06/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study. (2023/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Systemic Inflammatory Markers Predicting the Overall Survival of Patients Using Tyrosine Kinase Inhibitors in the First-line Treatment of Metastatic Renal Cell Carcinoma. (2023/06/01) ♡
• Kidney Cancer Updates from the 2023 American Society of Clinical Oncology Annual Meeting in Chicago. (2023/06/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.